CD8A and cancer: The fact that both cancer cells and CD8+ T cells utilize overlapping forms of metabolism in the TME is an important obstacle to overcome for the development of effective immunotherapies because cancer cells will likely outcompete CD8+ T cells for any available nutrients (6).